Markou AN - Search Results

1

Circulating miRNAs as Tumor Biomarkers: A Preface to the Special Issue.

Markou AN. Markou AN. Cancers (Basel). 2020 Dec 18;12(12):3836. doi: 10.3390/cancers12123836. Cancers (Basel). 2020. PMID: 33353205 Free PMC article.

2

The Role of CTCs as Tumor Biomarkers.

Lianidou ES, Markou A, Strati A. Lianidou ES, et al. Adv Exp Med Biol. 2015;867:341-67. doi: 10.1007/978-94-017-7215-0_21. Adv Exp Med Biol. 2015. PMID: 26530376 Review.

3

PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients.

Markou A, Tzanikou E, Strati A, Zavridou M, Mastoraki S, Bournakis E, Lianidou E. Markou A, et al. Cancers (Basel). 2020 May 8;12(5):1188. doi: 10.3390/cancers12051188. Cancers (Basel). 2020. PMID: 32397108 Free PMC article.

4

ESR1 NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of ESR1 Mutations in Liquid Biopsies.

Stergiopoulou D, Markou A, Tzanikou E, Ladas I, Makrigiorgos GM, Georgoulias V, Lianidou E. Stergiopoulou D, et al. Cancers (Basel). 2021 Feb 1;13(3):556. doi: 10.3390/cancers13030556. Cancers (Basel). 2021. PMID: 33535614 Free PMC article.

5

Generation of Non-Small Cell Lung Cancer Patient-Derived Xenografts to Study Intratumor Heterogeneity.

Kanaki Z, Voutsina A, Markou A, Pateras IS, Potaris K, Avgeris M, Makrythanasis P, Athanasiadis EI, Vamvakaris I, Patsea E, Vachlas K, Lianidou E, Georgoulias V, Kotsakis A, Klinakis A. Kanaki Z, et al. Cancers (Basel). 2021 May 18;13(10):2446. doi: 10.3390/cancers13102446. Cancers (Basel). 2021. PMID: 34070013 Free PMC article.

6

Zafeiriadou A, Kollias I, Londra T, Tsaroucha E, Georgoulias V, Kotsakis A, Lianidou E, Markou A. Zafeiriadou A, et al. Cancers (Basel). 2022 Jun 30;14(13):3237. doi: 10.3390/cancers14133237. Cancers (Basel). 2022. PMID: 35805008 Free PMC article.

7

Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients.

Stergiopoulou D, Markou A, Giannopoulou L, Buderath P, Balgkouranidou I, Xenidis N, Kakolyris S, Kasimir-Bauer S, Lianidou E. Stergiopoulou D, et al. Cancers (Basel). 2022 Aug 4;14(15):3790. doi: 10.3390/cancers14153790. Cancers (Basel). 2022. PMID: 35954453 Free PMC article.

8

Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer.

Markou AN, Londra D, Stergiopoulou D, Vamvakaris I, Potaris K, Pateras IS, Kotsakis A, Georgoulias V, Lianidou E. Markou AN, et al. Cancers (Basel). 2023 Mar 21;15(6):1877. doi: 10.3390/cancers15061877. Cancers (Basel). 2023. PMID: 36980762 Free PMC article.

9

Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting.

Strati A, Markou A, Kyriakopoulou E, Lianidou E. Strati A, et al. Cancers (Basel). 2023 Apr 6;15(7):2185. doi: 10.3390/cancers15072185. Cancers (Basel). 2023. PMID: 37046848 Free PMC article. Review.

10

Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC.

Bafiti V, Thanou E, Ouzounis S, Kotsakis A, Georgoulias V, Lianidou E, Katsila T, Markou A. Bafiti V, et al. Cancers (Basel). 2024 Nov 5;16(22):3729. doi: 10.3390/cancers16223729. Cancers (Basel). 2024. PMID: 39594687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters